Literature DB >> 4971183

[Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].

S Tada, T Hakamada, O Mori, Y Yamazaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4971183

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN： 0018-1994


× No keyword cloud information.
  2 in total

1.  Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

Authors:  Jae-Hyun Lee; Chang-Min Lee; Joyce H Lee; Mun-Ock Kim; Jin Wook Park; Suchitra Kamle; Bedia Akosman; Erica L Herzog; Xue Yan Peng; Jack A Elias; Chun Geun Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

2.  Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19.

Authors:  Suchitra Kamle; Bing Ma; Chuan Hua He; Bedia Akosman; Yang Zhou; Chang-Min Lee; Wafik S El-Deiry; Kelsey Huntington; Olin Liang; Jason T Machan; Min-Jong Kang; Hyeon Jun Shin; Emiko Mizoguchi; Chun Geun Lee; Jack A Elias
Journal:  JCI Insight       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.